• AgraFlora (AGRA) received a newly issued Standard Processing License from Health Canada for edibles manufacturing facility in Winnipeg, Manitoba
  • The 51,000 square-foot fully automated facility employs state-of-the-art manufacturing equipment to produce pharmaceutical-grade quality cannabis edibles
  • With the licence in hand, AgraFlora is continuing to focus on devloping long-term production relationships
  • AgraFlora closed at C$0.03 per share

AgraFlora (AGRA) received a newly issued Standard Processing License from Health Canada for edibles manufacturing facility in Winnipeg, Manitoba.

AgraFlora Organics is focused primarily on the Canadian cannabis industry. It’s subsidiary, Edibles and Infusions Corporation will be located in the Winnipeg facility.

The 51,000 square-foot fully automated facility employs state-of-the-art manufacturing equipment to produce pharmaceutical-grade quality cannabis edibles with a precise level of consistency for improved dosing accuracy, consistent consumer experiences and increased consumer safety. 

Edibles and Infusions Corporation Co-Founder and Operational Founder James Fletcher said the company’s strong evidence package submission is a testament to the hard-working team it has assembled.

“We are now able to commercialize our formulations and bring to market cannabis activated pectin and gelatin gummies, hard candy, and sugar-free variants.”

Looking forward, AgraFlora intends to continue focusing on completing long-term production relationships through the culmination of the research and development trials through the company’s Health Canada license.

AgraFlora closed at C$0.03 per share.

More From The Market Online

Tilray’s Breckenridge Brewery honours Denver Nuggets with new ale

Tilray Brands (TSX:TLRY) subsidiary Breckenridge Brewery launches a new ale to recognize the 2023 NBA championship-winning Denver Nuggets.

Avicanna launches 10% CBD (THC free) formula in Canada

Avicanna (TSX:AVCN) launches RHO Phyto Micro Drop 100, a 10 per cent CBD (THC free), proprietary oral formulation in Canada.

Organigram looks to raise capital as cannabis stocks surge

Organigram (TSX:OGI), one of Canada's first cannabis stocks, announces an overnight marketed public offering of units for up to C$25 million.